financetom
Business
financetom
/
Business
/
Illumin Down 15% As Q2 Net Loss Widens, Despite Higher Revs; Flags Further Restructure Costs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Illumin Down 15% As Q2 Net Loss Widens, Despite Higher Revs; Flags Further Restructure Costs
Aug 7, 2025 8:08 AM

10:34 AM EDT, 08/07/2025 (MT Newswires) -- Illumin Holdings ( ILLMF ) , an advertising technology platform, was down 15% at last look on Thursday after saying its net loss widened in the second quarter on restructuring costs, even as its revenues rose, and it flagged further expenses while decreasing its real estate footprint by the end of 2025.

The company reported a net loss of $5.8 million, swelling from a year-ago net loss of $1.0 million. It said this was primarily a result of lower Adjusted EBITDA, a net foreign exchange loss versus a gain in the prior year period, and higher severance expenses as part of the organizational restructuring completed near the end of the quarter.

Revenue increased to $33.1 million from $29.2 million, driven by revenue growth in exchange service and self service. partially offset by a decrease in Managed service.

Adjusted EBITDA showed a loss of $981,000, compared to a profit of $515,000 in the prior year period.

Illumin ( ILLMF ) said the actions associated with its cost reduction and restructuring initiatives, net of planned growth within the salesforce and other critical areas, will have reduced its North American workforce by 10%. In addition, the company will be decreasing its real estate footprint, reorganizing sales, marketing, and administrative activities to lower expenses "while identifying efficiencies to drive sales and conduct operations more effectively". The company expects to complete these initiatives by year end.

"As we enter the second half of the year, we're focused on a clear product differentiation strategy, pursuing our client acquisition strategy and expansion, and further streamlining operations to support our cost controls as we navigate a shifting market," CEO Simon Cairns said.

"Partly due to the changes we see in Managed service, we implemented a number of cost reduction and restructuring initiatives late in the quarter to enhance our profitability in the near term. These include changes throughout our management team, a reduction in our total workforce, and reprioritized planned investments in research and development, and marketing. We expect these initiatives will improve our financial profile, generate higher margins, and drive towards positive cash flow while still enabling us to focus on enhancing the customer lifetime value of our platform and our ability to generate platform returns over time."

Price: 1.75, Change: -0.40, Percent Change: -18.60

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Venture Global says new LNG environmental review unnecessary
Venture Global says new LNG environmental review unnecessary
Dec 4, 2024
HOUSTON/WASHINGTON, Dec 4 (Reuters) - Venture Global LNG on Wednesday slammed a U.S. call for an additional environmental review of a proposed Louisiana LNG project as unnecessary, adding that it will be ready to begin construction once the project gets a final go-ahead. The Federal Regulatory Energy Commission (FERC) last week pulled Venture Global LNG's authorization to construct its CP2...
Market Chatter: Teleflex in Talks to Buy Biotronik's Vascular Intervention Unit
Market Chatter: Teleflex in Talks to Buy Biotronik's Vascular Intervention Unit
Dec 4, 2024
03:53 PM EST, 12/04/2024 (MT Newswires) -- Teleflex ( TFX ) is negotiating a deal to acquire Biotronik's vascular intervention unit for 500 million euros ($525.7 million) to 1 billion euros, Bloomberg reported Wednesday, citing people familiar with the matter. An agreement could be finalized as soon as this month, a person reportedly said. Discussions are still underway and could...
US FDA approves Merus' therapy to treat lung, pancreatic cancers
US FDA approves Merus' therapy to treat lung, pancreatic cancers
Dec 4, 2024
Dec 4 (Reuters) - The U.S. Food and Drug Administration approved Merus NV's ( MRUS ) therapy to treat patients with types of lung and pancreatic cancers on Wednesday. ...
Soy traders push to weaken ban on buying from deforested Amazon
Soy traders push to weaken ban on buying from deforested Amazon
Dec 4, 2024
* Amazon soy moratorium credited for reducing deforestation * Traders do not buy from farms deforested since 2008 * Change would allow buying soy from parts of such farms (Recasts with environmentalists' interviews) SAO PAULO, Dec 4 (Reuters) - Multinational grains traders operating in Brazil are seeking to weaken an agreement that forbids buying soybeans from farms on deforested land...
Copyright 2023-2026 - www.financetom.com All Rights Reserved